abs333.txt	gene	therapy	has	demonstrated	effectiveness	in	many	genetic	diseases		asevidenced	by	recent	clinical	applications	viral	vectors	have	been	extensivelytested	gene-therapy	trials	but	nonviral	such	as	cationicpolymers	or	lipids	are	much	less	used	due	to	their	lower	gene-transfectionefficiencies	however	the	advantages	of	easilytailored	structures	nonimmunogenetics	and	relatively	low	cost	still	drivegreat	efforts	improve	transfection	efficiencies	a	reverse	question	asksif	with	current	efficiency	can	findapplication	niches	herein	we	synthesized	cationic	polymer	poly{n-[2-(acryloyloxy)ethyl]-	n-[	p-acetyloxyphenyl]-	n	n-diethylammonium	chloride}(pqdea)	gene-delivery	carrier	compared	it	side	withchemotherapy	drugs	for	cancer	treatment	pqdea	is	rapidly	hydrolyzed	byintracellular	esterases	into	anionic	poly(acrylic	acid)	give	cytotoxicityand	fast	release	dna	expression	formed	stable	complexes	dna(pqdea/dna	polyplexes)	which	were	further	coated	lipid	layer	makeserum-stable	lipidic	polyplexes	lpqdea/dnas	vivo	use	anintraperitoneal	tumor	xenograft	model	mimicking	late-stage	metastatic	cervicalcancer	lpqdea/dna	vector	trail	suicide	exerted	strong	tumorinhibition	effective	paclitaxel	first-line	anticancer	drug	gavemuch	relapse	longer	survival	than	chemotherapydrugs	irinotecan	equally	important	showed	muchfewer	adverse	effects	chemotherapy	this	work	shows	that	nonviralvectors	may	produce	therapeutic	advantagesand	be	safe	worthy	translation	example	intraperitoneal
